← Leaderboards
Emmanuel Fulgence Drabo
Johns Hopkins University
$376,101
Attributed
$752,201
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $429.9K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$752,201 · 2
By mechanism
R33$429,915 · 1
R61$322,286 · 1
Top collaborators
- Jodi B Segal2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jennifer L Wolff$21,462,393
- Carrie L Nieman$4,480,899
- Leigh E Boulware$39,736,144
- Deanna L Kerrigan$7,962,613
- Pauline M Maki$14,436,003
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposDisadvantagedCohort StudiesAmericanAgingAmyloid Beta-ProteinAffectAntibodiesAttitudeBehavioralCalibrationAmyloid Beta-42CognitiveCognitive InterviewAdoptionCostCost EffectivenessCost Effectiveness AnalysisCost EstimateCost Of DementiaDecision MakingDementiaDesignDisparity Population
Grant awards (2)
Using the generalized risk-adjusted cost-effectiveness (GRACE) model to advance an efficient and fair use of novel treatments for Alzheimerâs Disease and Related Dementias$429,915
R33 · FY2025 · AG
Using the generalized risk-adjusted cost-effectiveness (GRACE) model to advance health equity in use of novel treatments for Alzheimer's Disease and Related Dementias$322,286
R61 · FY2024 · AG